The David H. Koch Institute for Integrative Cancer Research at MITThe David H. Koch Institute for Integrative Cancer Research at MIT

Massachusetts Institute of Technology

National Cancer Institute Cancer Center

Science + Engineering... Conquering Cancer Together

Four KI trainees recognized as Forbes 30 Under 30

The KI boasts a great deal of young talent, and Forbes agrees! Forbes published its fourth annual 30 Under 30 lists in January, recognizing young game changers, movers, and makers in various fields. Four KI-affiliated trainees were named to the lists: two in the healthcare category, and two in the science category.

Canan Dagdeviren (Science), a postdoc in the Langer Lab, is creating implantable devices that can be powered by the energy generated from organs’ natural movements. By eliminating the need for batteries, she offers a glimpse at what devices such as pacemakers may look like in the not-so-distant future.

Christopher Lee (Healthcare), a graduate student in the Cima Lab, is co-founder of Recon Therapeutics, which has developed a new drug-delivery technology that can enable patients to self-administer injections simply and safely. His academic research is focused on helping patients expedite the passage of stones in the urinary tract.

Armon Sharei (Healthcare), a postdoc who received his PhD in the Langer and Jensen Labs, is squeezing cells to put therapeutics inside. After developing the platform CellSqueeze with KI support, he co-founded SQZ Biotech to commercialize this microfluidic technology.

Jason Sheltzer (Science), a graduate student in the Amon Lab, wants to fix science’s gender gap by addressing the “leaky pipeline.” In a study published last year, he found that women are greatly underrepresented in the labs of elite male biology faculty, suggesting that this may be a huge factor in why women are also underrepresented in faculty positions.